ARTICLE | Clinical News
Revlimid lenalidomide: Interim Phase III data
April 18, 2005 7:00 AM UTC
Interim data from the double-blind, placebo-controlled, international Phase III MM-010 trial in 351 patients showed that Revlimid plus dexamethasone met the primary endpoint of improvement in TTP vs. ...